| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 67.285.966 $ | 99,87 | 1.726.013 | |||||||
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 4.979.153 $ | 7,39 | 37.039 | |
| Vertex Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 4.969.484 $ | 7,38 | 11.104 | |
| Amgen Inc. | Amgen Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 4.786.796 $ | 7,10 | 14.213 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 3.424.325 $ | 5,08 | 5.570 | |
| Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 2.147.078 $ | 3,19 | 7.110 | |
| Revolution Medicines, Inc. | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 1.673.068 $ | 2,48 | 10.624 | |
| Biogen Inc. | Biogen Inc. | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 1.542.128 $ | 2,29 | 7.868 | |
| Illumina, Inc. | Illumina, Inc. | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 1.335.783 $ | 1,98 | 8.197 | |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 1.308.527 $ | 1,94 | 2.350 | |
| Royalty Pharma PLC | Royalty Pharma PLC, Class A | EC | G7709Q104 | Long | Börsenkurs (Stufe 1) | 1.280.696 $ | 1,90 | 22.968 | |
| argenx SE | argenx SE, ADR | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 1.271.541 $ | 1,89 | 1.521 | |
| Insmed Inc. | Insmed Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 1.235.452 $ | 1,83 | 11.556 | |
| Roivant Sciences Ltd. | Roivant Sciences Ltd. | EC | G76279101 | Long | Börsenkurs (Stufe 1) | 1.150.716 $ | 1,71 | 38.370 | |
| Incyte Corp. | Incyte Corp. | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 1.032.119 $ | 1,53 | 10.669 | |
| Viatris Inc. | Viatris Inc. | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 1.003.697 $ | 1,49 | 61.728 | |
| Moderna, Inc. | Moderna, Inc. | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 999.154 $ | 1,48 | 21.173 | |
| Guardant Health, Inc. | Guardant Health, Inc. | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 911.980 $ | 1,35 | 7.032 | |
| Neurocrine Biosciences, Inc. | Neurocrine Biosciences, Inc. | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 851.812 $ | 1,26 | 5.381 | |
| Jazz Pharmaceuticals PLC | Jazz Pharmaceuticals PLC | EC | G50871105 | Long | Börsenkurs (Stufe 1) | 780.417 $ | 1,16 | 3.300 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | K08588103 | Long | Börsenkurs (Stufe 1) | 739.787 $ | 1,10 | 3.301 | |
| Summit Therapeutics Inc. | Summit Therapeutics Inc. | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 729.120 $ | 1,08 | 41.569 | |
| Exelixis, Inc. | Exelixis, Inc. | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 702.833 $ | 1,04 | 13.923 | |
| BridgeBio Pharma, Inc. | BridgeBio Pharma, Inc. | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 688.640 $ | 1,02 | 10.393 | |
| Medpace Holdings, Inc. | Medpace Holdings, Inc. | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 680.501 $ | 1,01 | 1.522 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 677.484 $ | 1,01 | 8.856 | |
| Axsome Therapeutics, Inc. | Axsome Therapeutics, Inc. | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 642.944 $ | 0,95 | 2.742 | |
| Madrigal Pharmaceuticals, Inc. | Madrigal Pharmaceuticals, Inc. | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 611.642 $ | 0,91 | 1.230 | |
| BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 590.717 $ | 0,88 | 10.311 | |
| BioNTech SE | BioNTech SE, ADR | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 586.446 $ | 0,87 | 6.112 | |
| Arrowhead Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 584.870 $ | 0,87 | 7.507 | |
| Sanofi | Sanofi, ADR | EC | 80105N105 | Long | Börsenkurs (Stufe 1) | 573.038 $ | 0,85 | 13.122 | |
| Praxis Precision Medicines, Inc. | Praxis Precision Medicines, Inc. | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 522.505 $ | 0,78 | 1.493 | |
| Cytokinetics, Inc. | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 506.386 $ | 0,75 | 6.597 | |
| BeOne Medicines Ltd. | BeOne Medicines Ltd., ADR | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 493.495 $ | 0,73 | 1.714 | |
| Krystal Biotech, Inc. | Krystal Biotech, Inc. | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 484.250 $ | 0,72 | 1.567 | |
| Tempus AI, Inc. | Tempus AI, Inc., Class A | EC | 88023B103 | Long | Börsenkurs (Stufe 1) | 470.078 $ | 0,70 | 9.314 | |
| Abivax S.A. | Abivax S.A., ADR | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 436.883 $ | 0,65 | 3.294 | |
| Nuvalent, Inc. | Nuvalent, Inc., Class A | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 433.060 $ | 0,64 | 3.923 | |
| Halozyme Therapeutics, Inc. | Halozyme Therapeutics, Inc. | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 420.999 $ | 0,62 | 6.327 | |
| ImmunityBio, Inc. | ImmunityBio, Inc. | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 414.495 $ | 0,62 | 55.119 | |
| Vaxcyte, Inc. | Vaxcyte, Inc. | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 396.602 $ | 0,59 | 7.716 | |
| Alkermes PLC | Alkermes PLC | EC | G01767105 | Long | Börsenkurs (Stufe 1) | 376.925 $ | 0,56 | 8.934 | |
| Immunovant, Inc. | Immunovant, Inc. | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 363.370 $ | 0,54 | 10.912 | |
| Kymera Therapeutics, Inc. | Kymera Therapeutics, Inc. | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 356.375 $ | 0,53 | 4.377 | |
| Protagonist Therapeutics, Inc. | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 340.595 $ | 0,51 | 3.421 | |
| Mirum Pharmaceuticals, Inc. | Mirum Pharmaceuticals, Inc. | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 328.353 $ | 0,49 | 3.235 | |
| PTC Therapeutics, Inc. | PTC Therapeutics, Inc. | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 327.377 $ | 0,49 | 4.433 | |
| Rhythm Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 323.340 $ | 0,48 | 3.661 | |
| Spyre Therapeutics, Inc. | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 309.215 $ | 0,46 | 4.207 | |
| Cogent Biosciences, Inc. | Cogent Biosciences, Inc. | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 304.222 $ | 0,45 | 8.702 | |
| CRISPR Therapeutics AG | CRISPR Therapeutics AG | EC | H17182108 | Long | Börsenkurs (Stufe 1) | 288.540 $ | 0,43 | 5.136 | |
| CG Oncology, Inc. | CG Oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 281.987 $ | 0,42 | 4.527 | |
| Scholar Rock Holding Corp. | Scholar Rock Holding Corp. | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 269.079 $ | 0,40 | 5.458 | |
| Centessa Pharmaceuticals PLC | Centessa Pharmaceuticals PLC, ADR | EC | 152309100 | Long | Börsenkurs (Stufe 1) | 254.504 $ | 0,38 | 6.401 | |
| Caris Life Sciences, Inc. | Caris Life Sciences, Inc. | EC | 142152107 | Long | Börsenkurs (Stufe 1) | 252.322 $ | 0,37 | 15.091 | |
| Ligand Pharmaceuticals Inc. | Ligand Pharmaceuticals Inc. | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 247.965 $ | 0,37 | 1.069 | |
| Xenon Pharmaceuticals Inc. | Xenon Pharmaceuticals Inc. | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 243.822 $ | 0,36 | 4.455 | |
| Indivior Pharmaceuticals, Inc. | Indivior Pharmaceuticals, Inc. | EC | 45579U109 | Long | Börsenkurs (Stufe 1) | 241.226 $ | 0,36 | 6.697 | |
| Apogee Therapeutics, Inc. | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 240.917 $ | 0,36 | 2.933 | |
| Travere Therapeutics, Inc. | Travere Therapeutics, Inc. | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 233.399 $ | 0,35 | 4.947 | |
| Amneal Pharmaceuticals, Inc. | Amneal Pharmaceuticals, Inc. | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 222.086 $ | 0,33 | 16.863 | |
| Twist Bioscience Corp. | Twist Bioscience Corp. | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 219.802 $ | 0,33 | 3.287 | |
| Erasca, Inc. | Erasca, Inc. | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 213.105 $ | 0,32 | 16.597 | |
| NewAmsterdam Pharma Co. N.V. | NewAmsterdam Pharma Co. N.V. | EC | N62509109 | Long | Börsenkurs (Stufe 1) | 207.839 $ | 0,31 | 6.171 | |
| Crinetics Pharmaceuticals, Inc. | Crinetics Pharmaceuticals, Inc. | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 199.542 $ | 0,30 | 5.613 | |
| Acadia Pharmaceuticals Inc. | Acadia Pharmaceuticals Inc. | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 198.059 $ | 0,29 | 9.144 | |
| Veracyte, Inc. | Veracyte, Inc. | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 197.408 $ | 0,29 | 4.260 | |
| Edgewise Therapeutics, Inc. | Edgewise Therapeutics, Inc. | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 196.454 $ | 0,29 | 5.751 | |
| Beam Therapeutics Inc. | Beam Therapeutics Inc. | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 179.831 $ | 0,27 | 5.461 | |
| Denali Therapeutics Inc. | Denali Therapeutics Inc. | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 178.882 $ | 0,27 | 8.502 | |
| 10x Genomics, Inc. | 10x Genomics, Inc., Class A | EC | 88025U109 | Long | Börsenkurs (Stufe 1) | 178.576 $ | 0,27 | 6.309 | |
| Dyne Therapeutics, Inc. | Dyne Therapeutics, Inc. | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 170.626 $ | 0,25 | 8.827 | |
| Structure Therapeutics Inc. | Structure Therapeutics Inc., ADR | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 164.284 $ | 0,24 | 4.176 | |
| Tango Therapeutics Inc. | Tango Therapeutics Inc. | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 158.696 $ | 0,24 | 7.220 | |
| Oruka Therapeutics, Inc. | Oruka Therapeutics, Inc. | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 151.885 $ | 0,23 | 2.595 | |
| GRAIL, Inc. | GRAIL, Inc. | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 150.098 $ | 0,22 | 2.094 | |
| Alumis Inc. | Alumis Inc. | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 146.405 $ | 0,22 | 6.778 | |
| Arcutis Biotherapeutics, Inc. | Arcutis Biotherapeutics, Inc. | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 142.709 $ | 0,21 | 6.650 | |
| Disc Medicine, Inc. | Disc Medicine, Inc. | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 142.340 $ | 0,21 | 2.046 | |
| Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 141.957 $ | 0,21 | 3.074 | |
| IDEAYA Biosciences, Inc. | IDEAYA Biosciences, Inc. | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 138.745 $ | 0,21 | 4.708 | |
| Vera Therapeutics, Inc. | Vera Therapeutics, Inc. | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 135.864 $ | 0,20 | 3.825 | |
| Tarsus Pharmaceuticals, Inc. | Tarsus Pharmaceuticals, Inc. | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 135.551 $ | 0,20 | 2.282 | |
| Relay Therapeutics, Inc. | Relay Therapeutics, Inc. | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 134.627 $ | 0,20 | 9.582 | |
| Mineralys Therapeutics, Inc. | Mineralys Therapeutics, Inc. | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 133.655 $ | 0,20 | 4.243 | |
| Definium Therapeutics, Inc. | Definium Therapeutics, Inc. | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 129.296 $ | 0,19 | 5.345 | |
| Enliven Therapeutics, Inc. | Enliven Therapeutics, Inc. | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 125.912 $ | 0,19 | 3.182 | |
| Adaptive Biotechnologies Corp. | Adaptive Biotechnologies Corp. | EC | 00650F109 | Long | Börsenkurs (Stufe 1) | 125.063 $ | 0,19 | 8.255 | |
| Ultragenyx Pharmaceutical Inc. | Ultragenyx Pharmaceutical Inc. | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 124.009 $ | 0,18 | 5.180 | |
| Legend Biotech Corp. | Legend Biotech Corp., ADR | EC | 52490G102 | Long | Börsenkurs (Stufe 1) | 122.899 $ | 0,18 | 4.525 | |
| Kodiak Sciences Inc. | Kodiak Sciences Inc. | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 120.152 $ | 0,18 | 3.273 | |
| BioCryst Pharmaceuticals, Inc. | BioCryst Pharmaceuticals, Inc. | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 119.804 $ | 0,18 | 13.446 | |
| Kiniksa Pharmaceuticals International, PLC | Kiniksa Pharmaceuticals International, PLC | EC | G52694109 | Long | Börsenkurs (Stufe 1) | 119.063 $ | 0,18 | 2.461 | |
| Aurinia Pharmaceuticals Inc. | Aurinia Pharmaceuticals Inc. | EC | 05156V102 | Long | Börsenkurs (Stufe 1) | 109.288 $ | 0,16 | 7.129 | |
| Ocular Therapeutix, Inc. | Ocular Therapeutix, Inc. | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 105.156 $ | 0,16 | 11.671 | |
| Pharvaris N.V. | Pharvaris N.V. | EC | N69605108 | Long | Börsenkurs (Stufe 1) | 103.841 $ | 0,15 | 3.443 | |
| NovoCure Ltd. | NovoCure Ltd. | EC | G6674U108 | Long | Börsenkurs (Stufe 1) | 103.467 $ | 0,15 | 6.072 | |
| Sionna Therapeutics, Inc. | Sionna Therapeutics, Inc. | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 102.468 $ | 0,15 | 2.393 | |
| ADMA Biologics, Inc. | ADMA Biologics, Inc. | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 101.889 $ | 0,15 | 12.768 | |
| Rapport Therapeutics, Inc. | Rapport Therapeutics, Inc. | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 101.673 $ | 0,15 | 2.574 | |
| AbCellera Biologics Inc. | AbCellera Biologics Inc. | EC | 00288U106 | Long | Börsenkurs (Stufe 1) | 100.281 $ | 0,15 | 16.253 | |
| Zymeworks Inc. | Zymeworks Inc. | EC | 98985Y108 | Long | Börsenkurs (Stufe 1) | 100.244 $ | 0,15 | 3.989 | |
| Sarepta Therapeutics, Inc. | Sarepta Therapeutics, Inc. | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 99.840 $ | 0,15 | 5.587 | |
| Recursion Pharmaceuticals, Inc. | Recursion Pharmaceuticals, Inc., Class A | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 99.824 $ | 0,15 | 27.806 | |
| Nurix Therapeutics, Inc. | Nurix Therapeutics, Inc. | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 97.414 $ | 0,14 | 5.485 | |
| Harmony Biosciences Holdings, Inc. | Harmony Biosciences Holdings, Inc. | EC | 413197104 | Long | Börsenkurs (Stufe 1) | 97.392 $ | 0,14 | 3.083 | |
| Trevi Therapeutics, Inc. | Trevi Therapeutics, Inc. | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 96.576 $ | 0,14 | 6.830 | |
| Novavax, Inc. | Novavax, Inc. | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 95.823 $ | 0,14 | 8.735 | |
| Tyra Biosciences, Inc. | Tyra Biosciences, Inc. | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 95.586 $ | 0,14 | 2.861 | |
| uniQure N.V. | uniQure N.V. | EC | N90064101 | Long | Börsenkurs (Stufe 1) | 95.290 $ | 0,14 | 3.340 | |
| Stoke Therapeutics, Inc. | Stoke Therapeutics, Inc. | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 95.203 $ | 0,14 | 3.080 | |
| ANI Pharmaceuticals, Inc. | ANI Pharmaceuticals, Inc. | EC | 00182C103 | Long | Börsenkurs (Stufe 1) | 94.369 $ | 0,14 | 1.202 | |
| Syndax Pharmaceuticals, Inc. | Syndax Pharmaceuticals, Inc. | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 92.641 $ | 0,14 | 4.729 | |
| Agios Pharmaceuticals, Inc. | Agios Pharmaceuticals, Inc. | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 91.728 $ | 0,14 | 3.120 | |
| Genmab A/S | Genmab A/S, ADR | EC | 372303206 | Long | Börsenkurs (Stufe 1) | 90.391 $ | 0,13 | 3.433 | |
| Iovance Biotherapeutics, Inc. | Iovance Biotherapeutics, Inc. | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 90.216 $ | 0,13 | 22.004 | |
| Vericel Corp. | Vericel Corp. | EC | 92346J108 | Long | Börsenkurs (Stufe 1) | 90.091 $ | 0,13 | 2.703 | |
| Intellia Therapeutics, Inc. | Intellia Therapeutics, Inc. | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 88.430 $ | 0,13 | 6.285 | |
| AtaiBeckley Inc. | AtaiBeckley Inc. | EC | 04650F101 | Long | Börsenkurs (Stufe 1) | 87.687 $ | 0,13 | 19.357 | |
| Taysha Gene Therapies Inc. | Taysha Gene Therapies Inc. | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 85.743 $ | 0,13 | 14.607 | |
| Innoviva, Inc. | Innoviva, Inc. | EC | 45781M101 | Long | Börsenkurs (Stufe 1) | 85.059 $ | 0,13 | 3.971 | |
| Amylyx Pharmaceuticals, Inc. | Amylyx Pharmaceuticals, Inc. | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 84.765 $ | 0,13 | 5.907 | |
| AnaptysBio, Inc. | AnaptysBio, Inc. | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 82.614 $ | 0,12 | 1.484 | |
| Precigen, Inc. | Precigen, Inc. | EC | 74017N105 | Long | Börsenkurs (Stufe 1) | 82.039 $ | 0,12 | 18.903 | |
| Inhibrx Biosciences, Inc. | Inhibrx Biosciences, Inc. | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 80.816 $ | 0,12 | 777 | |
| Monte Rosa Therapeutics, Inc. | Monte Rosa Therapeutics, Inc. | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 80.101 $ | 0,12 | 4.064 | |
| Vir Biotechnology, Inc. | Vir Biotechnology, Inc. | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 79.888 $ | 0,12 | 8.374 | |
| Ardelyx, Inc. | Ardelyx, Inc. | EC | 039697107 | Long | Börsenkurs (Stufe 1) | 79.873 $ | 0,12 | 13.224 | |
| GH Research PLC | GH Research PLC | EC | G3855L106 | Long | Börsenkurs (Stufe 1) | 79.767 $ | 0,12 | 3.325 | |
| Fortrea Holdings Inc. | Fortrea Holdings Inc. | EC | 34965K107 | Long | Börsenkurs (Stufe 1) | 77.150 $ | 0,11 | 5.013 | |
| MBX Biosciences, Inc. | MBX Biosciences, Inc. | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 75.748 $ | 0,11 | 2.407 | |
| KalVista Pharmaceuticals, Inc. | KalVista Pharmaceuticals, Inc. | EC | 483497103 | Long | Börsenkurs (Stufe 1) | 73.516 $ | 0,11 | 2.736 | |
| Bicara Therapeutics Inc. | Bicara Therapeutics Inc. | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 73.515 $ | 0,11 | 3.380 | |
| Septerna, Inc. | Septerna, Inc. | EC | 81734D104 | Long | Börsenkurs (Stufe 1) | 71.665 $ | 0,11 | 2.373 | |
| UroGen Pharma Ltd. | UroGen Pharma Ltd. | EC | M96088105 | Long | Börsenkurs (Stufe 1) | 70.578 $ | 0,10 | 2.509 | |
| Harrow, Inc. | Harrow, Inc. | EC | 415858109 | Long | Börsenkurs (Stufe 1) | 69.364 $ | 0,10 | 1.970 | |
| Maze Therapeutics, Inc. | Maze Therapeutics, Inc. | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 68.267 $ | 0,10 | 2.580 | |
| Immunocore Holdings PLC | Immunocore Holdings PLC, ADR | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 67.920 $ | 0,10 | 2.351 | |
| ArriVent Biopharma, Inc. | ArriVent Biopharma, Inc. | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 66.624 $ | 0,10 | 2.201 | |
| Wave Life Sciences Ltd. | Wave Life Sciences Ltd. | EC | Y95308105 | Long | Börsenkurs (Stufe 1) | 66.412 $ | 0,10 | 10.093 | |
| COMPASS Pathways PLC | COMPASS Pathways PLC, ADR | EC | 20451W101 | Long | Börsenkurs (Stufe 1) | 66.031 $ | 0,10 | 5.056 | |
| Personalis, Inc. | Personalis, Inc. | EC | 71535D106 | Long | Börsenkurs (Stufe 1) | 63.031 $ | 0,09 | 5.529 | |
| MannKind Corp. | MannKind Corp. | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 62.273 $ | 0,09 | 16.518 | |
| EyePoint, Inc. | EyePoint, Inc. | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 60.268 $ | 0,09 | 4.438 | |
| Alvotech | Alvotech | EC | L01800108 | Long | Börsenkurs (Stufe 1) | 59.496 $ | 0,09 | 17.707 | |
| Savara Inc. | Savara Inc. | EC | 805111101 | Long | Börsenkurs (Stufe 1) | 56.722 $ | 0,08 | 10.908 | |
| Collegium Pharmaceutical, Inc. | Collegium Pharmaceutical, Inc. | EC | 19459J104 | Long | Börsenkurs (Stufe 1) | 56.633 $ | 0,08 | 1.685 | |
| Olema Pharmaceuticals, Inc. | Olema Pharmaceuticals, Inc. | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 56.466 $ | 0,08 | 4.281 | |
| Corvus Pharmaceuticals, Inc. | Corvus Pharmaceuticals, Inc. | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 54.939 $ | 0,08 | 4.427 | |
| Xeris Biopharma Holdings, Inc. | Xeris Biopharma Holdings, Inc. | EC | 98422E103 | Long | Börsenkurs (Stufe 1) | 54.793 $ | 0,08 | 8.895 | |
| AbSci Corp. | AbSci Corp. | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 54.716 $ | 0,08 | 8.106 | |
| Zenas Biopharma, Inc. | Zenas Biopharma, Inc. | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 52.955 $ | 0,08 | 2.878 | |
| Cullinan Therapeutics, Inc. | Cullinan Therapeutics, Inc. | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 52.065 $ | 0,08 | 3.167 | |
| Grifols, S.A. | Grifols, S.A., ADR | EC | 398438408 | Long | Börsenkurs (Stufe 1) | 51.339 $ | 0,08 | 6.540 | |
| Pacira Biosciences, Inc. | Pacira Biosciences, Inc. | EC | 695127100 | Long | Börsenkurs (Stufe 1) | 49.853 $ | 0,07 | 2.147 | |
| ARS Pharmaceuticals, Inc. | ARS Pharmaceuticals, Inc. | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 48.352 $ | 0,07 | 5.331 | |
| Sana Biotechnology, Inc. | Sana Biotechnology, Inc. | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 47.421 $ | 0,07 | 14.370 | |
| Arbutus Biopharma Corp. | Arbutus Biopharma Corp. | EC | 03879J100 | Long | Börsenkurs (Stufe 1) | 47.018 $ | 0,07 | 10.311 | |
| Kura Oncology, Inc. | Kura Oncology, Inc. | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 46.889 $ | 0,07 | 4.597 | |
| Janux Therapeutics, Inc. | Janux Therapeutics, Inc. | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 46.878 $ | 0,07 | 3.213 | |
| Xencor, Inc. | Xencor, Inc. | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 46.712 $ | 0,07 | 3.932 | |
| MeiraGTx Holdings PLC | MeiraGTx Holdings PLC | EC | G59665102 | Long | Börsenkurs (Stufe 1) | 45.955 $ | 0,07 | 4.315 | |
| Amphastar Pharmaceuticals, Inc. | Amphastar Pharmaceuticals, Inc. | EC | 03209R103 | Long | Börsenkurs (Stufe 1) | 45.806 $ | 0,07 | 2.430 | |
| ORIC Pharmaceuticals, Inc. | ORIC Pharmaceuticals, Inc. | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 44.819 $ | 0,07 | 5.304 | |
| Theravance Biopharma Inc. | Theravance Biopharma Inc. | EC | G8807B106 | Long | Börsenkurs (Stufe 1) | 43.635 $ | 0,06 | 2.717 | |
| Eton Pharmaceuticals, Inc. | Eton Pharmaceuticals, Inc. | EC | 29772L108 | Long | Börsenkurs (Stufe 1) | 43.269 $ | 0,06 | 1.421 | |
| Geron Corp. | Geron Corp. | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 42.779 $ | 0,06 | 34.223 | |
| Mesoblast Ltd. | Mesoblast Ltd., ADR | EC | 590717401 | Long | Börsenkurs (Stufe 1) | 42.612 $ | 0,06 | 2.767 | |
| Annexon, Inc. | Annexon, Inc. | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 42.319 $ | 0,06 | 7.808 | |
| Omeros Corp. | Omeros Corp. | EC | 682143102 | Long | Börsenkurs (Stufe 1) | 41.963 $ | 0,06 | 3.801 | |
| Phathom Pharmaceuticals, Inc. | Phathom Pharmaceuticals, Inc. | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 40.719 $ | 0,06 | 4.246 | |
| BioAge Labs, Inc. | BioAge Labs, Inc. | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 39.663 $ | 0,06 | 2.294 | |
| Esperion Therapeutics, Inc. | Esperion Therapeutics, Inc. | EC | 29664W105 | Long | Börsenkurs (Stufe 1) | 39.447 $ | 0,06 | 12.603 | |
| Replimune Group, Inc. | Replimune Group, Inc. | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 37.906 $ | 0,06 | 4.362 | |
| Maravai LifeSciences Holdings, Inc. | Maravai LifeSciences Holdings, Inc., Class A | EC | 56600D107 | Long | Börsenkurs (Stufe 1) | 37.080 $ | 0,06 | 7.725 | |
| CorMedix Inc. | CorMedix Inc. | EC | 21900C308 | Long | Börsenkurs (Stufe 1) | 35.153 $ | 0,05 | 4.165 | |
| Zevra Therapeutics, Inc. | Zevra Therapeutics, Inc. | EC | 488445206 | Long | Börsenkurs (Stufe 1) | 34.457 $ | 0,05 | 2.973 | |
| Phibro Animal Health Corp. | Phibro Animal Health Corp., Class A | EC | 71742Q106 | Long | Börsenkurs (Stufe 1) | 33.931 $ | 0,05 | 1.102 | |
| Prime Medicine, Inc. | Prime Medicine, Inc. | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 33.810 $ | 0,05 | 9.524 | |
| Vor BioPharma Inc. | Vor BioPharma Inc. | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 33.578 $ | 0,05 | 2.243 | |
| Castle Biosciences, Inc. | Castle Biosciences, Inc. | EC | 14843C105 | Long | Börsenkurs (Stufe 1) | 33.011 $ | 0,05 | 1.566 | |
| CytomX Therapeutics, Inc. | CytomX Therapeutics, Inc. | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 32.148 $ | 0,05 | 8.930 | |
| Candel Therapeutics, Inc. | Candel Therapeutics, Inc. | EC | 137404109 | Long | Börsenkurs (Stufe 1) | 32.088 $ | 0,05 | 3.866 | |
| Zai Lab Ltd. | Zai Lab Ltd., ADR | EC | 98887Q104 | Long | Börsenkurs (Stufe 1) | 32.001 $ | 0,05 | 1.809 | |
| Design Therapeutics, Inc. | Design Therapeutics, Inc. | EC | 25056L103 | Long | Börsenkurs (Stufe 1) | 31.566 $ | 0,05 | 3.012 | |
| Tectonic Therapeutic, Inc. | Tectonic Therapeutic, Inc. | EC | 878972108 | Long | Börsenkurs (Stufe 1) | 31.165 $ | 0,05 | 1.000 | |
| Ironwood Pharmaceuticals, Inc. | Ironwood Pharmaceuticals, Inc. | EC | 46333X108 | Long | Börsenkurs (Stufe 1) | 30.706 $ | 0,05 | 8.601 | |
| Arvinas, Inc. | Arvinas, Inc. | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 30.272 $ | 0,04 | 3.371 | |
| Solid Biosciences Inc. | Solid Biosciences Inc. | EC | 83422E204 | Long | Börsenkurs (Stufe 1) | 30.197 $ | 0,04 | 4.114 | |
| Rigel Pharmaceuticals, Inc. | Rigel Pharmaceuticals, Inc. | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 29.362 $ | 0,04 | 963 | |
| Aclaris Therapeutics, Inc. | Aclaris Therapeutics, Inc. | EC | 00461U105 | Long | Börsenkurs (Stufe 1) | 28.956 $ | 0,04 | 6.364 | |
| Prothena Corp. PLC | Prothena Corp. PLC | EC | G72800108 | Long | Börsenkurs (Stufe 1) | 28.789 $ | 0,04 | 2.828 | |
| 4D Molecular Therapeutics, Inc. | 4D Molecular Therapeutics, Inc. | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 26.638 $ | 0,04 | 2.688 | |
| Aquestive Therapeutics, Inc. | Aquestive Therapeutics, Inc. | EC | 03843E104 | Long | Börsenkurs (Stufe 1) | 25.893 $ | 0,04 | 6.441 | |
| Kyverna Therapeutics, Inc. | Kyverna Therapeutics, Inc. | EC | 501976104 | Long | Börsenkurs (Stufe 1) | 25.747 $ | 0,04 | 3.022 | |
| Allogene Therapeutics, Inc. | Allogene Therapeutics, Inc. | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 25.745 $ | 0,04 | 11.864 | |
| Aura Biosciences, Inc. | Aura Biosciences, Inc. | EC | 05153U107 | Long | Börsenkurs (Stufe 1) | 24.987 $ | 0,04 | 3.345 | |
| Fulcrum Therapeutics, Inc. | Fulcrum Therapeutics, Inc. | EC | 359616109 | Long | Börsenkurs (Stufe 1) | 24.227 $ | 0,04 | 3.501 | |
| Kamada Ltd. | Kamada Ltd. | EC | M6240T109 | Long | Börsenkurs (Stufe 1) | 23.852 $ | 0,04 | 3.054 | |
| Neurogene Inc. | Neurogene Inc. | EC | 64135M105 | Long | Börsenkurs (Stufe 1) | 23.777 $ | 0,04 | 839 | |
| Upstream Bio, Inc. | Upstream Bio, Inc. | EC | 91678A107 | Long | Börsenkurs (Stufe 1) | 23.742 $ | 0,04 | 2.840 | |
| Pacific Biosciences of California, Inc. | Pacific Biosciences of California, Inc. | EC | 69404D108 | Long | Börsenkurs (Stufe 1) | 23.742 $ | 0,04 | 15.934 | |
| First Tracks Biotherapeutics, Inc. | First Tracks Biotherapeutics, Inc. | EC | 337185102 | Long | Börsenkurs (Stufe 1) | 23.493 $ | 0,03 | 1.472 | |
| Lakefront Biotherapeutics N.V. | Lakefront Biotherapeutics N.V., ADR | EC | 36315X101 | Long | Börsenkurs (Stufe 1) | 22.510 $ | 0,03 | 794 | |
| C4 Therapeutics, Inc. | C4 Therapeutics, Inc. | EC | 12529R107 | Long | Börsenkurs (Stufe 1) | 22.462 $ | 0,03 | 5.140 | |
| Evolus, Inc. | Evolus, Inc. | EC | 30052C107 | Long | Börsenkurs (Stufe 1) | 22.448 $ | 0,03 | 3.422 | |
| Contineum Therapeutics, Inc. | Contineum Therapeutics, Inc., Class A | EC | 21217B100 | Long | Börsenkurs (Stufe 1) | 21.692 $ | 0,03 | 1.608 | |
| OmniAb, Inc. | OmniAb, Inc. | EC | 68218J103 | Long | Börsenkurs (Stufe 1) | 20.471 $ | 0,03 | 7.832 | |
| Altimmune, Inc. | Altimmune, Inc. | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 20.164 $ | 0,03 | 6.611 | |
| Vanda Pharmaceuticals Inc. | Vanda Pharmaceuticals Inc. | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 20.072 $ | 0,03 | 3.112 | |
| Enanta Pharmaceuticals, Inc. | Enanta Pharmaceuticals, Inc. | EC | 29251M106 | Long | Börsenkurs (Stufe 1) | 20.069 $ | 0,03 | 1.525 | |
| Larimar Therapeutics, Inc. | Larimar Therapeutics, Inc. | EC | 517125100 | Long | Börsenkurs (Stufe 1) | 19.961 $ | 0,03 | 5.736 | |
| Lexeo Therapeutics, Inc. | Lexeo Therapeutics, Inc. | EC | 52886X107 | Long | Börsenkurs (Stufe 1) | 19.789 $ | 0,03 | 3.850 | |
| Autolus Therapeutics PLC | Autolus Therapeutics PLC, ADR | EC | 05280R100 | Long | Börsenkurs (Stufe 1) | 19.775 $ | 0,03 | 10.575 | |
| Immuneering Corp. | Immuneering Corp., Class A | EC | 45254E107 | Long | Börsenkurs (Stufe 1) | 19.658 $ | 0,03 | 3.407 | |
| Lyell Immunopharma, Inc. | Lyell Immunopharma, Inc. | EC | 55083R203 | Long | Börsenkurs (Stufe 1) | 19.392 $ | 0,03 | 1.119 | |
| Atea Pharmaceuticals, Inc. | Atea Pharmaceuticals, Inc. | EC | 04683R106 | Long | Börsenkurs (Stufe 1) | 19.273 $ | 0,03 | 4.127 | |
| Puma Biotechnology, Inc. | Puma Biotechnology, Inc. | EC | 74587V107 | Long | Börsenkurs (Stufe 1) | 19.216 $ | 0,03 | 2.680 | |
| Cabaletta Bio, Inc. | Cabaletta Bio, Inc. | EC | 12674W109 | Long | Börsenkurs (Stufe 1) | 19.214 $ | 0,03 | 5.083 | |
| REGENXBIO Inc. | REGENXBIO Inc. | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 18.682 $ | 0,03 | 2.665 | |
| Keros Therapeutics, Inc. | Keros Therapeutics, Inc. | EC | 492327101 | Long | Börsenkurs (Stufe 1) | 18.113 $ | 0,03 | 1.610 | |
| Editas Medicine, Inc. | Editas Medicine, Inc. | EC | 28106W103 | Long | Börsenkurs (Stufe 1) | 17.795 $ | 0,03 | 5.143 | |
| SIGA Technologies, Inc. | SIGA Technologies, Inc. | EC | 826917106 | Long | Börsenkurs (Stufe 1) | 17.639 $ | 0,03 | 3.769 | |
| Rocket Pharmaceuticals, Inc. | Rocket Pharmaceuticals, Inc. | EC | 77313F106 | Long | Börsenkurs (Stufe 1) | 17.606 $ | 0,03 | 5.735 | |
| Silence Therapeutics PLC | Silence Therapeutics PLC, ADR | EC | 82686Q101 | Long | Börsenkurs (Stufe 1) | 17.084 $ | 0,03 | 2.476 | |
| Invivyd, Inc. | Invivyd, Inc. | EC | 00534A102 | Long | Börsenkurs (Stufe 1) | 16.652 $ | 0,02 | 14.607 | |
| Neumora Therapeutics, Inc. | Neumora Therapeutics, Inc. | EC | 640979100 | Long | Börsenkurs (Stufe 1) | 16.302 $ | 0,02 | 8.812 | |
| Alpha Teknova, Inc. | Alpha Teknova, Inc. | EC | 02080L102 | Long | Börsenkurs (Stufe 1) | 15.250 $ | 0,02 | 2.824 | |
| Anavex Life Sciences Corp. | Anavex Life Sciences Corp. | EC | 032797300 | Long | Börsenkurs (Stufe 1) | 14.780 $ | 0,02 | 4.878 | |
| Entrada Therapeutics, Inc. | Entrada Therapeutics, Inc. | EC | 29384C108 | Long | Börsenkurs (Stufe 1) | 14.260 $ | 0,02 | 2.017 | |
| AC Immune S.A. | AC Immune S.A. | EC | H00263105 | Long | Börsenkurs (Stufe 1) | 14.130 $ | 0,02 | 5.312 | |
| Humacyte, Inc. | Humacyte, Inc. | EC | 44486Q103 | Long | Börsenkurs (Stufe 1) | 13.234 $ | 0,02 | 10.180 | |
| Codexis, Inc. | Codexis, Inc. | EC | 192005106 | Long | Börsenkurs (Stufe 1) | 13.202 $ | 0,02 | 4.766 | |
| Foghorn Therapeutics Inc. | Foghorn Therapeutics Inc. | EC | 344174107 | Long | Börsenkurs (Stufe 1) | 13.187 $ | 0,02 | 3.081 | |
| LENZ Therapeutics, Inc. | LENZ Therapeutics, Inc. | EC | 52635N103 | Long | Börsenkurs (Stufe 1) | 12.899 $ | 0,02 | 1.658 | |
| Coherus Oncology, Inc. | Coherus Oncology, Inc. | EC | 19249H103 | Long | Börsenkurs (Stufe 1) | 12.529 $ | 0,02 | 7.880 | |
| Quantum-Si Inc. | Quantum-Si Inc. | EC | 74765K105 | Long | Börsenkurs (Stufe 1) | 12.262 $ | 0,02 | 10.304 | |
| Voyager Therapeutics, Inc. | Voyager Therapeutics, Inc. | EC | 92915B106 | Long | Börsenkurs (Stufe 1) | 12.005 $ | 0,02 | 3.102 | |
| Sagimet Biosciences Inc. | Sagimet Biosciences Inc., Class A | EC | 786700104 | Long | Börsenkurs (Stufe 1) | 11.963 $ | 0,02 | 1.641 | |
| Arcturus Therapeutics Holdings Inc. | Arcturus Therapeutics Holdings Inc. | EC | 03969T109 | Long | Börsenkurs (Stufe 1) | 11.793 $ | 0,02 | 1.489 | |
| Orchestra Biomed Holdings, Inc. | Orchestra Biomed Holdings, Inc. | EC | 68572M106 | Long | Börsenkurs (Stufe 1) | 11.664 $ | 0,02 | 2.983 | |
| Caribou Biosciences, Inc. | Caribou Biosciences, Inc. | EC | 142038108 | Long | Börsenkurs (Stufe 1) | 11.623 $ | 0,02 | 4.925 | |
| Bicycle Therapeutics PLC | Bicycle Therapeutics PLC, ADR | EC | 088786108 | Long | Börsenkurs (Stufe 1) | 11.439 $ | 0,02 | 2.439 | |
| NovaBridge Biosciences | NovaBridge Biosciences, ADR | EC | 44975P103 | Long | Börsenkurs (Stufe 1) | 10.902 $ | 0,02 | 5.925 | |
| Tenaya Therapeutics, Inc. | Tenaya Therapeutics, Inc. | EC | 87990A106 | Long | Börsenkurs (Stufe 1) | 9.925 $ | 0,01 | 11.421 | |
| Lifecore Biomedical, Inc. | Lifecore Biomedical, Inc. | EC | 514766104 | Long | Börsenkurs (Stufe 1) | 9.884 $ | 0,01 | 1.969 | |
| Jyong Biotech Ltd. | Jyong Biotech Ltd. | EC | G83116106 | Long | Börsenkurs (Stufe 1) | 8.633 $ | 0,01 | 3.924 | |
| Black Diamond Therapeutics, Inc. | Black Diamond Therapeutics, Inc. | EC | 09203E105 | Long | Börsenkurs (Stufe 1) | 6.689 $ | 0,01 | 3.013 | |
| Pyxis Oncology, Inc. | Pyxis Oncology, Inc. | EC | 747324101 | Long | Börsenkurs (Stufe 1) | 5.900 $ | 0,01 | 3.278 | |
| PepGen Inc. | PepGen Inc. | EC | 713317105 | Long | Börsenkurs (Stufe 1) | 5.441 $ | 0,01 | 3.627 | |
| Rani Therapeutics Holdings, Inc. | Rani Therapeutics Holdings, Inc., Class A | EC | 753018100 | Long | Börsenkurs (Stufe 1) | 4.886 $ | 0,01 | 5.139 | |
| Aardvark Therapeutics, Inc. | Aardvark Therapeutics, Inc. | EC | 002942100 | Long | Börsenkurs (Stufe 1) | 4.727 $ | 0,01 | 1.150 | |
| Gossamer Bio, Inc. | Gossamer Bio, Inc. | EC | 38341P102 | Long | Börsenkurs (Stufe 1) | 2.819 $ | 0,00 | 12.208 | |
| Cartesian Therapeutics, Inc. | Cartesian Therapeutics, Inc., Rts., 2050-12-31 | EC | 816212112 | Long | Schätzwert (Stufe 3) | 359 $ | 0,00 | 2.633 | |
| Third Harmonic Bio, Inc. | Third Harmonic Bio, Inc., Class B | EC | 88427A107 | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 1.605 | |
| Novo Nordisk A/S | Novo Nordisk A/S | EC | 009CVR044 | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 3.794 | |
| 67.285.966 $ | 99,87 | 1.726.013 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
aufsichtsrechtlicher Pflichtmeldungen und öffentlicher Register und stellen keine
Bewertung oder Empfehlung zu einzelnen Wertpapieren, Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher Pflichtmeldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.